生物谷
(833266)
| 流通市值：8.15亿 | | | 总市值：12.98亿 |
| 流通股本：7785.52万 | | | 总股本：1.24亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 92,345,006.45 | 101,396,563.47 | 227,187,187.28 | 230,760,200.35 |
| 应收票据及应收账款 | 121,621,000.84 | 115,728,924.31 | 99,272,534.29 | 99,598,352.56 |
| 其中：应收票据 | 548,464.8 | 2,180,690.5 | 6,827,116.21 | 2,709,455.28 |
| 应收账款 | 121,072,536.04 | 113,548,233.81 | 92,445,418.08 | 96,888,897.28 |
| 应收款项融资 | 3,481,248.37 | 13,870,368.83 | 18,711,798.5 | 21,401,508.67 |
| 预付款项 | 47,398,860.94 | 39,878,276.17 | 3,960,218.17 | 3,245,812.86 |
| 其他应收款合计 | 64,772,822.75 | 64,251,871.26 | 115,764,218.26 | 115,726,107 |
| 存货 | 111,933,353.18 | 112,974,080.39 | 107,993,088.15 | 104,490,752.62 |
| 一年内到期的非流动资产 | 229,089.82 | 223,108.42 | 220,291.85 | 216,521.3 |
| 其他流动资产 | 1,648,095.14 | 4,873,010.87 | 6,407,207.79 | 6,152,891.06 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 513,462,121.01 | 546,033,405.54 | 629,640,571 | 631,716,173.13 |
| 非流动资产: | | | | |
| 长期应收款 | 29,577,010.36 | 29,577,421.63 | 29,574,668.07 | 29,572,868.49 |
| 其他非流动金融资产 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 |
| 固定资产 | 320,242,283.04 | 324,210,801.83 | 283,933,805.44 | 287,936,565.83 |
| 在建工程 | 97,479,576.95 | 93,665,218.22 | 126,682,566.97 | 123,850,929.37 |
| 使用权资产 | 18,661.34 | 73,617.25 | 2,975,963.6 | 4,228,402.83 |
| 无形资产 | 90,995,858.3 | 91,677,109.31 | 92,266,915 | 92,949,360.7 |
| 递延所得税资产 | 41,186,982.01 | 40,084,972.73 | 30,546,854.19 | 30,809,131.6 |
| 其他非流动资产 | 7,337,577.13 | 7,224,828.52 | 5,977,948.52 | 5,384,771.47 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 599,337,949.13 | 599,013,969.49 | 584,458,721.79 | 587,232,030.29 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,112,800,070.14 | 1,145,047,375.03 | 1,214,099,292.79 | 1,218,948,203.42 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 31,894,308.67 | 37,607,982.31 | 31,745,507.8 | 30,964,245.51 |
| 应付账款 | 31,894,308.67 | 37,607,982.31 | 31,745,507.8 | 30,964,245.51 |
| 合同负债 | 665,230.56 | 794,172.82 | 1,787,922.47 | 1,664,962.82 |
| 应付职工薪酬 | 3,687,692.26 | 20,583,727.74 | 2,781,288.6 | 4,410,634.83 |
| 应交税费 | 7,985,970.74 | 10,870,426.63 | 7,771,355.32 | 4,994,781.08 |
| 其他应付款合计 | 31,574,953.64 | 19,299,164.35 | 18,713,541.76 | 19,538,654.74 |
| 一年内到期的非流动负债 | 34,084,835.72 | 34,120,885.8 | 31,301,771.91 | 34,802,346.65 |
| 其他流动负债 | 634,944.75 | 503,242.47 | 1,431,020.94 | 500,570.98 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 110,527,936.34 | 123,779,602.12 | 95,532,408.8 | 96,876,196.61 |
| 非流动负债: | | | | |
| 长期借款 | 18,750,000 | 18,750,000 | 37,500,000 | 37,500,000 |
| 租赁负债 | 636,716.42 | 455,189.86 | 815,438.6 | 626,557.22 |
| 递延收益 | 74,455,562.87 | 76,859,717.46 | 78,721,871.05 | 79,646,904.23 |
| 递延所得税负债 | 120,773.04 | 125,580.29 | 260,807.85 | 18,604.01 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 93,963,052.33 | 96,190,487.61 | 117,298,117.5 | 117,792,065.46 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 204,490,988.67 | 219,970,089.73 | 212,830,526.3 | 214,668,262.07 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 124,000,007 | 124,000,007 | 124,000,007 | 124,000,007 |
| 资本公积 | 396,600,116.59 | 396,600,116.59 | 396,600,116.59 | 396,600,116.59 |
| 减:库存股 | 5,140,700.12 | 5,140,700.12 | 5,140,700.12 | 5,140,700.12 |
| 盈余公积 | 68,242,259.73 | 68,242,259.73 | 68,242,259.73 | 68,242,259.73 |
| 未分配利润 | 324,607,398.27 | 341,375,602.1 | 417,567,083.29 | 420,578,258.15 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 908,309,081.47 | 925,077,285.3 | 1,001,268,766.49 | 1,004,279,941.35 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 908,309,081.47 | 925,077,285.3 | 1,001,268,766.49 | 1,004,279,941.35 |
| 负债和股东权益合计 | 1,112,800,070.14 | 1,145,047,375.03 | 1,214,099,292.79 | 1,218,948,203.42 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-29 | 2024-08-26 |
| 审计意见(境内) | | 保留意见 | | |